Evidence map›Paper›PMID 26785135›Full record

ArticleNature communications2016

Autonomous beating rate adaptation in human stem cell-derived cardiomyocytes.

George Eng, Benjamin W Lee, Lev Protas, Mark Gagliardi, Kristy Brown, Robert S Kass, Gordon Keller, Richard B Robinson, Gordana Vunjak-Novakovic

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 96 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
96citing papers in PubMed, 1 pooled it
10.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

96 citing papers in PubMed, 1 synthesis or guideline pooled it, 181 citations in OpenAlex.

  1. Engineering the maturation of stem cell-derived cardiomyocytes.Frontiers in bioengineering and biotechnology · 2023
    Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Short-Term Electrical Stimulation Impacts Cardiac Cell Structure and Function.Journal of tissue engineering and regenerative medicine · 2025
    Article
  12. Novel, low-cost bioreactor forFrontiers in bioengineering and biotechnology · 2025
    Article
  13. Article
  14. Review
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article

36 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

George EngDepartment of Biomedical Engineering, Columbia University, New York, New York 10027, USA.
Benjamin W LeeDepartment of Biomedical Engineering, Columbia University, New York, New York 10027, USA.
Lev ProtasDepartment of Pharmacology, Columbia University, New York, New York 10032, USA.
Mark GagliardiMcEwen Centre for Regenerative Medicine, University Health Network, Toronto, Ontario, Canada M5G1L7.
Kristy BrownDepartment of Pathology and Cell Biology, Columbia University, New York, New York 10032, USA.
Robert S KassDepartment of Pharmacology, Columbia University, New York, New York 10032, USA.
Gordon KellerMcEwen Centre for Regenerative Medicine, University Health Network, Toronto, Ontario, Canada M5G1L7.
Richard B RobinsonDepartment of Pharmacology, Columbia University, New York, New York 10032, USA.
Gordana Vunjak-NovakovicDepartment of Biomedical Engineering, Columbia University, New York, New York 10027, USA.
Columbia University · USUniversity Health Network · CA

Funding

Translational Bioreactors - Engineering Complex TissuesP41EB002520 · NIBIB · TUFTS UNIVERSITY MEDFORD · PI KAPLAN, DAVID L. · 2004 to 2018
$16.7M
Engineering Vascularized Cardiac MuscleR01HL076485 · NHLBI · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI Gordana Vunjak-Novakovic · 2005 to 2026
$9.2M
Tissue Chips for Rare Disease: Adding Timothy Syndrome to the HeLIVaSkCa platformUH3EB017103 · NIBIB · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI VUNJAK-NOVAKOVIC, GORDANA · 2014 to 2016
$7.1M
Integrated heart-liver-vascular systems for drug testing in human health and diseUH2EB017103 · NIBIB · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI VUNJAK-NOVAKOVIC, GORDANA · 2012 to 2013
$1.7M
Biologically Inspired Engineering of Hierarchical Vascular NetworksF30HL112505 · NHLBI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI ENG, GEORGE · 2012 to 2014
$117k
NHLBI NIH HHS F30 HL112505NHLBI NIH HHS HL076485NHLBI NIH HHS R01 HL076485NIBIB NIH HHS EB002520NIBIB NIH HHS P41 EB002520NIBIB NIH HHS UH2 EB017103NIBIB NIH HHS UH2 EB17103NIBIB NIH HHS UH3 EB017103
6 · The paper itself

Abstract

The therapeutic success of human stem cell-derived cardiomyocytes critically depends on their ability to respond to and integrate with the surrounding electromechanical environment. Currently, the immaturity of human cardiomyocytes derived from stem cells limits their utility for regenerative medicine and biological research. We hypothesize that biomimetic electrical signals regulate the intrinsic beating properties of cardiomyocytes. Here we show that electrical conditioning of human stem cell-derived cardiomyocytes in three-dimensional culture promotes cardiomyocyte maturation, alters their automaticity and enhances connexin expression. Cardiomyocytes adapt their autonomous beating rate to the frequency at which they were stimulated, an effect mediated by the emergence of a rapidly depolarizing cell population, and the expression of hERG. This rate-adaptive behaviour is long lasting and transferable to the surrounding cardiomyocytes. Thus, electrical conditioning may be used to promote cardiomyocyte maturation and establish their automaticity, with implications for cell-based reduction of arrhythmia during heart regeneration.

Indexed as

Cell DifferentiationConnexinsElectric StimulationERG1 Potassium ChannelEther-A-Go-Go Potassium ChannelsHumansMicroscopy, Electron, TransmissionMyocytes, CardiacPluripotent Stem CellsConnexinsERG1 Potassium ChannelEther-A-Go-Go Potassium ChannelsKCNH2 protein, human

Identifiers

PMID26785135
PMCPMC4735644
OpenAlexW2280539066

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.